Skip to main content
Guide

A Novel Doxorubicin-Mitomycin C Co-Encapsulated Nanoparticle Formulation Exhibits Anti-Cancer Synergy in Multidrug Resistant Human Breast Cancer Cells

Fasken
Reading Time 1 minute read

Breast Cancer Res. Treatment 2010; 119(2): 255-269

Richard Cheung co-wrote the piece titled, A Novel Doxorubicin-Mitomycin C Co-Encapsulated Nanoparticle Formulation Exhibits Anti-Cancer Synergy in Multidrug Resistant Human Breast Cancer Cells.